We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USLM:NASDAQUnited States Lime & Minerals, Inc. Analysis

Data as of 2026-05-28 - not real-time

$111.91

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its mid‑term and long‑term moving averages, with price comfortably above the short‑term average, suggesting a bearish medium‑term bias but a potential short‑term bounce. The relative strength index sits near the neutral zone, while the MACD line sits above its signal, generating a bullish histogram that hints at upside momentum. Market sentiment is in the extreme greed zone, yet the 30‑day volatility is markedly high and beta remains elevated, underscoring heightened price swings. Current price hovers above a well‑defined support level and below a clear resistance ceiling, framing a range where volume has been tapering, which could limit the strength of any breakout.
Fundamental outlook: The company delivers robust gross and operating margins, strong cash generation and a minimal debt load, supporting a modest dividend that is comfortably covered by earnings. However, revenue is contracting, and valuation multiples are high relative to peers, with the discounted cash‑flow model indicating a market price far above intrinsic value. The business operates in a cyclical building‑materials sector exposed to environmental regulation, adding a layer of sector‑specific risk despite a solid balance sheet. Overall, the combination of strong profitability, limited growth, and overvaluation suggests caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support with bullish MACD histogram
  • neutral RSI indicating limited immediate pressure
  • decreasing volume may constrain rapid moves

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • price below mid‑term and long‑term moving averages
  • negative revenue growth and high valuation multiples
  • strong cash flow but limited growth prospects

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • market price far exceeds DCF fair value
  • high volatility and elevated beta increase systematic risk
  • cyclical sector exposure and regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-3.70%
Profit Margin35.40%
P/E Ratio24.6
ROE21.91%
ROA14.79%
Debt/Equity0.55
P/B Ratio5.1
Op. Cash Flow$157.6M
Free Cash Flow$55.4M

Technical Analysis

TrendBearish
RSI48.2
Support$100.33
Resistance$132.90
MA 20$108.47
MA 50$121.42
MA 200$122.17
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5

Valuation

Fair Value$38.59
Target Price$138.00
Upside/Downside23.31%
GradeOvervalued
TypeValue
Dividend Yield0.22%

Risk Assessment

Beta1.43
Volatility60.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.